Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today requested amendments to the U.S. Emergency Use Authorization (EUA) of the Pfizer-BioNTech vaccine (BNT162b2) to […]
The vaccination strategy will pick up pace in the coming weeks, with a gradual and steady increase towards the end of the summer. The vaccination […]
…Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective […]
BioNTech SE today announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19 vaccine drug product at the facility in Marburg. As part […]
New stability data show vaccine can be stored at -25°C to -15°C for a total of two weeks and support decentralized distribution plans for vaccination […]
The reactivation of immunisation for the educational community will begin next Friday. The launch of the vaccination is to see, once again, the light at […]
“President Biden promised to bring down health care costs and that is exactly what we at the Department of Health and Human Services will do, […]
The autonomous communities have administered a total of 6,321,908 doses of Pfizer-BioNTech, Moderna and AstraZeneca’s covid-19 vaccines up to Monday, 328,545 of them during the […]
Clofamizine, a drug used to treat leprosy, is effective against SARS-CoV-2 infection in human cells and hamsters, according to a study published Tuesday in the […]
This interactive forum discusses the latest in cell and gene therapy trends and their potential to impact the economy. Blue Bell, Pennsylvania, March 19, 2021 […]
Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France. € 25 million investment in Molsheim, France, will create […]
As part of the Biden Administration’s ongoing efforts to promote health equity in response to the COVID-19 pandemic, the U.S. Department of Health and Human […]
Copyright © 2021 | WordPress Theme by MH Themes